Becton Dickinson & Co. BDX
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $21.8B | +8% | FY ending Sep 30, 2025 |
|---|---|---|---|
| Gross profit | $7.6B | -9% | FY ending Sep 30, 2020 |
| Operating income | $2.6B | +8% | FY ending Sep 30, 2025 |
| Net income | $1.7B | -2% | FY ending Sep 30, 2025 |
| Earnings per share | $5.82 | -1% | FY ending Sep 30, 2025 |
| Research & development | $1.3B | +6% | FY ending Sep 30, 2025 |
| Cash from operations | $4.6B | +31% | FY ending Sep 30, 2021 |
| Capital spending | $760.0M | +5% | FY ending Sep 30, 2025 |
| Share buybacks | $1.0B | +100% | FY ending Sep 30, 2025 |
| Dividends paid | $1.2B | +9% | FY ending Sep 30, 2025 |
| Cash | $641.0M | -63% | FY ending Sep 30, 2025 |
| Long-term debt | $17.6B | -2% | FY ending Sep 30, 2025 |
| Shareholders' equity | $25.4B | -2% | FY ending Sep 30, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 21 sales ($2.8M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Michael FeldEVP, Chief Revenue Officer | Soldpre-set plan | 76 | $198.13 | $15K | Oct 26, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Soldpre-set plan | 76 | $183.70 | $14K | Sep 28, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Soldpre-set plan | 165 | $188.49 | $31K | Aug 26, 2026 |
| Thomas E Jr PolenChairman, CEO and President, Director | Soldpre-set plan | 4,152 | $185.00 | $768K | Aug 13, 2026 |
| Roland GoetteEVP and President, EMEA | Sold | 2,438 | $180.84 | $441K | Aug 11, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Soldpre-set plan | 75 | $157.13 | $12K | Jul 27, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Soldpre-set plan | 75 | $152.80 | $11K | Jun 26, 2026 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Soldpre-set plan | 1,100 | $145.66 | $160K | Jun 24, 2026 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Soldpre-set plan | 1,100 | $151.48 | $167K | Jun 10, 2026 |
| Thomas E Jr PolenChairman, CEO and President, Director | Soldpre-set plan | 2,764 | $146.35 | $405K | Jun 1, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Soldpre-set plan | 75 | $147.35 | $11K | May 26, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Soldpre-set plan | 74 | $151.94 | $11K | Apr 27, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Soldpre-set plan | 75 | $156.83 | $12K | Mar 26, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Soldpre-set plan | 75 | $181.84 | $14K | Feb 26, 2026 |
| Bertram L ScottDirector | Sold | 953 | $182.61 | $174K | Feb 18, 2026 |
| Michael FeldEVP, CRO & Pres. Life Sciences | Soldpre-set plan | 75 | $202.73 | $15K | Jan 26, 2026 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Soldpre-set plan2 fills | 1,610 | $207.46 avg | $334K | Jan 15, 2026 |
| Michael FeldEVP, CRO & Pres. Life Sciences | Soldpre-set plan | 74 | $196.08 | $15K | Dec 26, 2025 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Soldpre-set plan | 629 | $196.03 | $123K | Dec 17, 2025 |
| Michael FeldEVP, CRO & Pres. Life Sciences | Soldpre-set plan | 75 | $193.36 | $15K | Dec 1, 2025 |
| Bertram L ScottDirector | Sold | 217 | $176.58 | $38K | Nov 7, 2025 |
Other insider moves (51): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Vitor RoqueEVP & Chief Financial Officer | Tax withholding | 190 | – | – | Sep 2, 2026 |
| Michael FeldEVP, Chief Revenue Officer | Tax withholding | 1,049 | – | – | Aug 20, 2026 |
| Thomas E Jr PolenChairman, CEO and President, Director | Returnedpre-set plan | 39,126 | $185.00 | $7.2M | Aug 13, 2026 |
| Thomas E Jr PolenChairman, CEO and President, Director | Option exercisepre-set plan | 43,278 | $167.25 | $7.2M | Aug 13, 2026 |
| Bilal MuhsinEVP & President Connected Care | Tax withholding | 1,935 | – | – | Jul 2, 2026 |
| Bilal MuhsinEVP & President Connected Care | Award | 14,342 | – | – | Jul 1, 2026 |
| Thomas E Jr PolenChairman, CEO and President, Director | Returnedpre-set plan | 17,445 | $146.15 | $2.5M | Jun 1, 2026 |
| Thomas E Jr PolenChairman, CEO and President, Director | Option exercisepre-set plan | 20,209 | $126.16 | $2.5M | Jun 1, 2026 |
| Peter MenziusoEVP and President, BDI | Award | 14,258 | – | – | Jun 1, 2026 |
| Vitor RoqueEVP & Chief Financial Officer | Award | 1,721 | – | – | May 7, 2026 |
| Shana Carol NealEVP and Chief People Officer | Tax withholding | 1,146 | – | – | Apr 6, 2026 |
| Lanesha MinnixEVP and General Counsel | Award | 7,492 | – | – | Mar 16, 2026 |
| Vitor RoqueInterim CFO | Award | 931 | – | – | Mar 2, 2026 |
| Pamela L. SpiknerSVP Controller & CAO | Award | 931 | – | – | Mar 2, 2026 |
| Becton Dickinson & Co10% owner | Other | 284,771,350 | – | – | Feb 9, 2026 |
| Jeffrey William HendersonDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| R Andrew EckertDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| Carrie L ByingtonDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| Gregory HayesDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| William M BrownDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| Robert Luther HuffinesDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| Christopher Ian Montague JonesDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| Timothy M RingDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| Bertram L ScottDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| Joanne WaldstreicherDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| Jacqueline WrightDirector | Award | 1,098 | – | – | Jan 27, 2026 |
| Pamela L. SpiknerSVP Controller & CAO | Tax withholding | 84 | – | – | Jan 21, 2026 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Returnedpre-set plan | 2,454 | $209.00 | $513K | Jan 15, 2026 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Option exercisepre-set plan | 3,054 | $167.91 | $513K | Jan 15, 2026 |
| David ShanEVP and Chief ISC Officer | Tax withholding | 44 | – | – | Jan 3, 2026 |
| Jacqueline WrightDirector | Award | 180 | – | – | Dec 1, 2025 |
| Robert Luther HuffinesDirector | Award | 180 | – | – | Dec 1, 2025 |
| Pavan Kumar MocherlaEVP & President, Greater Asia | Award2 fills | 2,916 | – | – | Nov 26, 2025 |
| David ShanEVP and Chief ISC Officer | Award2 fills | 4,529 | – | – | Nov 26, 2025 |
| David ShanEVP and Chief ISC Officer | Tax withholding | 134 | – | – | Nov 26, 2025 |
| Shana Carol NealEVP and Chief People Officer | Award2 fills | 10,252 | – | – | Nov 26, 2025 |
| Shana Carol NealEVP and Chief People Officer | Tax withholding | 2,454 | – | – | Nov 26, 2025 |
| Roland GoetteEVP and President, EMEA | Award2 fills | 3,143 | – | – | Nov 26, 2025 |
| Roland GoetteEVP and President, EMEA | Tax withholding | 138 | – | – | Nov 26, 2025 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Award2 fills | 10,616 | – | – | Nov 26, 2025 |
| Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Tax withholding | 1,769 | – | – | Nov 26, 2025 |
| Michael FeldEVP, CRO & Pres. Life Sciences | Award | 8,829 | – | – | Nov 26, 2025 |
| Michael FeldEVP, CRO & Pres. Life Sciences | Tax withholding | 419 | – | – | Nov 26, 2025 |
| Christopher DeloreficeEVP & Chief Financial Officer | Award | 6,006 | – | – | Nov 26, 2025 |
| Christopher DeloreficeEVP & Chief Financial Officer | Tax withholding | 4,245 | – | – | Nov 26, 2025 |
| Richard ByrdEVP & President Interventional | Award2 fills | 8,832 | – | – | Nov 26, 2025 |
| Richard ByrdEVP & President Interventional | Tax withholding | 1,719 | – | – | Nov 26, 2025 |
| Bilal MuhsinEVP & President Connected Care | Award | 9,530 | – | – | Nov 26, 2025 |
| Thomas E Jr PolenChairman, CEO and President | Award | 22,521 | – | – | Nov 26, 2025 |
| Thomas E Jr PolenChairman, CEO and President | Tax withholding | 17,421 | – | – | Nov 26, 2025 |
| Pamela L. SpiknerSVPController & Chief Acct Off | Award | 1,234 | – | – | Nov 26, 2025 |
Trades by members of Congress
5 members reported 3 buys and 5 sales since Mar 5, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Thomas H. Kean, Jr. R | Sold | $1,001–$15K | May 21, 2026 | Jun 18, 2026 | Self |
| Kevin Hern R | Sold | $15K–$50K | Mar 17, 2026 | Apr 3, 2026 | Joint |
| Lisa C. McClain R | Sold | $1,001–$15K | Jun 24, 2025 | Aug 13, 202550 days later | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jun 17, 2025 | Aug 13, 202557 days later | Spouse |
| Thomas H. Kean, Jr. R | Bought | $1,001–$15K | May 13, 2025 | Jun 17, 2025 | Self |
| Robert P. Bresnahan, Jr. R | Bought | $1,001–$15K | May 15, 2025 | Jun 9, 2025 | Self |
| Robert P. Bresnahan, Jr. R | Sold | $1,001–$15K | Apr 8, 2025 | Apr 28, 2025 | Self |
| Jefferson Shreve R | Sold | $15K–$50K | Mar 5, 2025 | Apr 11, 2025 | Self |
Latest SEC filings
- Insider plans to sell 144 · Oct 26, 2026
- Insider plans to sell 144 · Sep 28, 2026
- Insider plans to sell 144 · Aug 26, 2026
- Insider plans to sell 144 · Aug 20, 2026
- Insider plans to sell 144 · Aug 13, 2026
- Insider plans to sell 144 · Aug 11, 2026
- Quarterly report 10-Q · Aug 6, 2026
- News filing: Quarterly results 8-K · Aug 6, 2026
- Insider plans to sell 144 · Aug 3, 2026
- Insider plans to sell 144 · Jul 27, 2026
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Jul 22, 2026
- Insider plans to sell 144 · Jun 26, 2026
- Insider plans to sell 144 · Jun 24, 2026
- Insider plans to sell 144 · Jun 10, 2026
- Insider plans to sell 144 · Jun 1, 2026
- News filing: Public announcement (Reg FD) 8-K · May 29, 2026
- Insider plans to sell 144 · May 26, 2026
- News filing: Signed a major agreement, Took on new debt 8-K · May 20, 2026
- News filing: Other news 8-K · May 12, 2026
- Quarterly report 10-Q · May 7, 2026
- News filing: Quarterly results 8-K · May 7, 2026
- News filing: Bylaws or fiscal year changed 8-K · Apr 29, 2026
- Insider plans to sell 144 · Apr 27, 2026
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Apr 9, 2026
- News filing: Quarterly results 8-K · Apr 2, 2026
About Becton Dickinson & Co.
Business description
- Industry
- Surgical & Medical Instruments & Apparatus
- Sector
- Industrial Applications and Services
- Headquarters
- Franklin Lakes, NJ
- Incorporated in
- NJ
- Fiscal year ends
- September 30
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 10795
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.